Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across biomedical AI, cancer, cardiovascular diseases, immunity, age-related, rare and infectious diseases.

          Learn more

        • Biomedical AI
        • Cancer Innovations
        • Cardiovascular Research
        • Healthy Ageing
        • Infection & Immunity
        • Rare Diseases & Gene Therapy
        • Laboratories
        • Impact
        • Technologies
        • Commercialisation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research.

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your will
        • Donate in memory
        • Advise on our research
  • Careers & students
        • Careers & Students

          Postdoctoral and postgraduate students can work alongside world-leading medical researchers within state-of-the-art research facilities.

        • Careers
        • Study opportunities
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events.

        • News
        • Statements
        • Events
        • Real stories
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges.

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Animals in research
        • Contact
  • Donate
    Centenary Institute > News > Research to unlock the secrets of muscle loss in ageing

Research to unlock the secrets of muscle loss in ageing

Date time 28 September, 2023
News Type News type Media release
Associate Professor Andy Philp and Associate Professor Richard Mills
The Centenary Institute and the University of Technology Sydney will lead pioneering research into age-related muscle loss, called sarcopenia, with a Dynamic Resilience Program contract from Wellcome Leap.

A natural process, sarcopenia is where muscles become smaller and weaker due to ageing. This can lead to reduced mobility, increased frailty and overall decreased quality of life among older adults. Sarcopenia can also result from short term hospitalisation and bed rest in older individuals where inactivity leads to rapid and severe musculoskeletal wasting.

The research aims to shed light on why short-term hospitalisation in older adults leads to profound loss of muscle mass and strength, accelerating conditions of sarcopenia and frailty. The researchers will harness brand new technologies and techniques to explore the impacts of ageing on muscle function and develop potential interventions to enhance the quality of life for older individuals.

At the heart of the research investigation lies a novel model for studying human muscle ageing – tiny laboratory-grown human skeletal muscles, called micro-muscles.

Principal Investigator of the project, Associate Professor Andy Philp, Head of the Centenary Institute’s Centre for Healthy Ageing and Adjunct Associate Professor at the University of Technology Sydney said that their advanced micro-muscle model would be able to simulate age-related conditions like sarcopenia and hospitalisations to help unlock the secrets of skeletal muscle’s resilience to ageing and inactivity.

“Use of our novel bioengineered muscle platform in combination with patient-derived blood samples and advanced molecular analysis techniques, will help us decipher the intricate biological mechanisms underlying muscle ageing and wastage, as well as the muscle’s capacity for recovery,” said Associate Professor Philp.

The bioengineered micro-muscles, being developed by Co-Principal Investigator and Group Leader Associate Professor Richard Mills from the Murdoch Children’s Research Institute and Melbourne node of reNEW, are set to provide a revolutionary approach. 

“These micro-muscles offer an unprecedented lab-based platform for in-depth exploration of the intricate biological processes involved in sarcopenia,” said Associate Professor Mills.

Aspects that will be investigated include the role of age, gender, inactivity and inflammation-related stress on muscular function.

Associate Professor Philp said that the research holds the promise of transforming the way age-related muscle wasting is treated.

“We believe our innovative approach has the potential to lead to new therapeutic approaches to promote muscle strength and resilience, to ultimately enhance the well-being and vitality of ageing individuals,” he said.

The collaborative research program will be undertaken by researchers at the Centenary institute, University of Technology Sydney, Murdoch Children’s Research Institute, University of Sydney and the University of Leicester (UK).

Themes

  • Healthy Ageing

    Healthy Ageing

People

  • Professor Andy Philp

    Head, Centre for Healthy Ageing

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw

Phone number Phone Number +61 402 770 403

Email Email t.crawshaw@centenary.org.au

Media Release

Research to unlock the secrets of muscle loss in ageing

Download

Recent Stories

  • Blood test discovery could help identify head and neck cancer patients at higher risk of relapse

    Researchers at the Centenary Institute, Chris O’Brien Lifehouse, NSW Health Pathology and Royal Prince Alfred Hospital have found a potential new way to help doctors identify which head and neck cancer patients may be at higher risk of their cancer returning, using a simple blood test.
    News Type: Media release
    Date 25 Feb 2026
  • New FAP-Index could transform early detection of severe liver disease

    Researchers from the Centenary Institute have developed a new diagnostic tool, the FAP-Index, that could significantly improve how doctors identify people at risk of serious liver damage caused by metabolic fatty liver disease. The condition affects around one in three Australians with cases projected to increase by 25% to over 7 million by 2030.
    News Type: Media release
    Date 20 Feb 2026
  • First‑of‑its‑kind AI platform to improve cancer treatment decisions

    Centenary researchers have been awarded funding to commercialise a first‑of‑its‑kind medical AI platform designed to improve treatment decisions and reduce unnecessary surgeries for Australian cancer patients. The project, funded through the Australian Government’s Australia’s Economic Accelerator (AEA) Ignite program and led by Dr Yagiz Aksoy, Senior Clinical Research Fellow at Centenary’s Centre for Biomedical AI, ...
    News Type: Research News
    Date 19 Feb 2026
  • New initiative to allow researchers to decode disease like never before

    The Centenary Institute and the University of Sydney have launched a major new initiative that brings next-generation spatial biology technologies together to transform how health threats such as cancer, cardiovascular diseases and infectious diseases are studied and understood.
    News Type: Research News
    Date 11 Feb 2026

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About us
  • Governance
  • Corporate information

Research

  • Our researchers
  • News

Careers & studies

  • Career opportunities
  • Student opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement
  • Staff Intranet

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram